ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links0 made here, not in the record15 judgments3 judges (the rules as one: Rule based)1 record change seen
GPT-6 Astra (Medium)Model not recordedRule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07802821A Study Comparing QLC5508in Combination With QL2107Versus Tislelizumab PlusPlatinum-based Chemotherapyin Participants WihTreatment-naïveExtensive-Stage Small CellQilu Pharmaceutical Co., Ltd.Phase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 30 · ClinicalTrials.gov record · Version of 2026-10-30Version of 2026-10-30CONDITIONSSmall Cell Lung CarcinomaThe registry's MeSH filing›Oct 20 · GPT-6 Astra (Medium) · RightNov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionDRUGSQLC5508Intervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedQL2107Intervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · TestedBackgroundTislelizumabIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · ComparatorComparatorCarboplatinIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · ComparatorComparatorCisplatinIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · ComparatorComparatorEtoposideIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Small Cell Lung Carcinoma

From the registry record3 judgments on this link
Fit of the first condition term, from the registry to what was judged
RegistrySmall Cell Lung Carcinoma, as filedthe registry files the study under it
→judged
Kind of condition link
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Oct 20Small Cell Lung CarcinomaGPT-6 Astra (Medium)RightCurrent
Oct 30The record itselfClinicalTrials.gov recordVersion of 2026-10-30Record change
Nov 1QLC5508A model not recordedTestedCurrent
Nov 1QL2107A model not recordedBackgroundCurrent
Nov 1TislelizumabA model not recordedComparatorCurrent
Nov 1CarboplatinA model not recordedComparatorCurrent
Nov 1CisplatinA model not recordedComparatorCurrent
Nov 1EtoposideA model not recordedComparatorCurrent
Nov 14Small Cell Lung CarcinomaRule based · condition-kind ruleFinest filed termCurrent
Nov 18QLC5508Rule based · role ruleTestedAgrees
Nov 18QL2107Rule based · role ruleTestedOverridden
Nov 18TislelizumabRule based · role ruleComparatorAgrees
Nov 18CarboplatinRule based · role ruleComparatorAgrees
Nov 18CisplatinRule based · role ruleComparatorAgrees
Nov 18EtoposideRule based · role ruleComparatorAgrees
As of nowSmall Cell Lung CarcinomaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.